Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an announcement.
Recordati S.p.A. has updated the market on its share buyback program, which was initiated following a resolution by the Shareholders’ Meeting. The program aims to purchase shares to support the company’s stock option and performance share plans for management. Between January 13 and 17, 2025, Recordati purchased a total of 62,469 shares, bringing the total owned shares to 2,877,834, equivalent to 1.376% of the share capital. This initiative reflects Recordati’s commitment to incentivize management and align their interests with those of shareholders.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange. With roots tracing back to a family pharmacy in Northern Italy in the 1920s, the company offers therapeutic options in specialty pharmaceuticals, general medicine, and rare diseases. It operates in about 150 countries in the EMEA, Americas, and APAC regions, employing over 4,450 people.
YTD Price Performance: 8.40%
Average Trading Volume: 15,025
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €11.27B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.
